Giovan Battista Doglietto

Plain English
This study looked at the safety and effectiveness of robotic surgery for removing part of the pancreas in 236 patients across five medical centers from 2008 to 2016. Researchers found that the surgery had a low conversion rate (only 6.3% needed to switch to traditional surgery), preserved the spleen in nearly half of the cases (48.3%), and showed good cancer-related outcomes. Overall, the results show that robotic surgery is a safe option for treating pancreatic diseases, with acceptable rates of complications and death. Who this helps: This helps patients with pancreatic diseases and their surgeons.

Plain English
This study looked at how effective two types of surgery—open surgery and minimally invasive surgery (MIS)—are for treating rectal cancer in 237 patients. Researchers found that patients who underwent MIS had significantly less blood loss during surgery (127 mL) compared to those who had open surgery (242 mL), and MIS also allowed for more sphincter-preserving operations (110 vs. 75). Although both methods had similar complication rates and long-term survival outcomes, MIS could be a better option due to less blood loss, despite higher costs for robotic surgery compared to laparoscopic surgery. Who this helps: This helps patients with rectal cancer by providing options that may lead to less blood loss and better surgical outcomes.

Plain English
This study examined the outcomes of a surgical technique called Billroth II reconstruction in patients with gastric cancer, looking at data from 258 patients over a ten-year period. It found that only 1.5% of patients died as a result of the surgery, and 78% of patients survived for at least five years after the procedure. Additionally, younger patients and those with earlier-stage tumors had better survival rates, while complications and advanced cancers negatively impacted their chances of staying cancer-free. Who this helps: This helps patients with gastric cancer and their doctors in making informed decisions about surgery options.

Plain English
This study compared two types of surgery—robot-assisted (RDP) and laparoscopic (LDP)—for removing pancreatic neuroendocrine tumors (pNETs) across four medical centers from 2008 to 2016. The researchers found that RDP had a higher chance of preserving the spleen and resulted in less blood loss compared to LDP, but LDP was cheaper, costing about €9,235 versus €11,226 for RDP. Both methods were equally effective in terms of safety and long-term outcomes, but the higher costs of RDP might limit its use. Who this helps: This information benefits doctors and patients considering surgical options for pancreatic neuroendocrine tumors.

Plain English
This study looked at two different treatment approaches using a drug called capecitabine, combined with radiation, for patients with locally advanced rectal cancer. It found that the Xelac treatment was more effective at causing tumor shrinkage, with 61.7% of patients showing significant regression compared to 52.3% for Xelox, even though overall survival rates were similar for both treatments. This is important because choosing the most effective and least toxic treatment can greatly improve the quality of care for patients with this type of cancer. Who this helps: Patients with locally advanced rectal cancer.

Plain English
This study looked at two types of stomach surgery—total gastrectomy (TG) and proximal gastrectomy (PG)—to see how they affect patients with cancer in the upper part of the stomach. The researchers found that while both surgeries showed similar survival rates after five years (56.7% for PG and 46.5% for TG), PG was linked to a higher chance of complications like acid reflux and strictures in the esophagus. This matters because choosing the right surgical option can significantly affect a patient's recovery and quality of life. Who this helps: Patients with upper stomach cancer and their doctors.

Plain English
This study looked at a specific cancer treatment called hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) for patients with advanced abdominopelvic cancer. Over 17 years, 103 procedures were performed on 94 patients, and results showed that 49% were still alive after a median follow-up of 53 months, even though 46 experienced a return of their cancer. This matter because it shows that combining surgery with HIPEC improved survival rates, suggesting it’s a better option than surgery alone for this type of advanced cancer. Who this helps: This research benefits patients with advanced abdominopelvic cancer.

Plain English
This study looked at the results of robotic surgery for rectal cancer, reviewing 60 surgeries performed over four years. The findings showed that robotic surgery is safe and effective, with a 94% overall survival rate and an 87% disease-free survival rate after an average follow-up of about 33 months. It also had a low complication rate and a conversion rate to traditional surgery of just 5%, which is better than laparoscopic methods. Who this helps: This benefits patients with rectal cancer seeking advanced surgical options.

Plain English
This study looked at how unusual blood vessel arrangements in the abdomen affect outcomes after pancreatic surgery. It found that 25% of patients had these anatomical variations, which made surgeries longer and caused more blood loss. Furthermore, if doctors didn’t notice these variations before surgery, there was a higher chance of serious complications afterwards, like liver damage. Who this helps: This helps doctors and patients undergoing pancreatic surgery by highlighting the importance of detecting blood vessel variations beforehand.

Plain English
This study looked at how two different surgical methods (pancreaticojejunostomy and pancreatic duct occlusion) affect digestive function and blood sugar control in patients who had part of their pancreas removed. They found that 56% of patients using the first method had digestive issues compared to 100% of those using the second method. However, both groups had similar needs for enzyme supplements, blood sugar levels, and quality of life ratings. Who this helps: This information benefits patients facing pancreatic surgery by showing the relative effectiveness of different surgical options.

Plain English
This study looked at the effects of high blood sugar levels (hyperglycemia) in non-diabetic patients after gastric surgery for cancer. Out of 193 patients, 96 experienced high blood sugar after surgery, with 11 having severely high levels. Those with severe hyperglycemia faced much worse complications, with a 63.6% complication rate compared to 30.6% for mild hyperglycemia and 13% for normal blood sugar levels. Who this helps: This information helps doctors manage blood sugar levels better to improve outcomes for cancer surgery patients.

Plain English
This study looked at how the quality control of mitochondria, the cells’ powerhouses, is affected in the muscles of older patients with gastric cancer and cachexia, a condition characterized by severe weight loss and muscle wasting. The researchers found that cancer patients showed reduced levels of certain proteins crucial for mitochondrial function and signaling, pointing to a breakdown in muscle quality control. Specifically, they noted that one protein was lower in the cancer group compared to healthy controls, while another was increased in cachectic patients, highlighting significant changes across different muscle control pathways. Who this helps: This research can benefit doctors and healthcare providers in understanding and potentially treating cachexia in older cancer patients.

Plain English
This study looked at how stomach cancer spreads to lymph nodes, which are important for determining the disease's severity. Researchers found that lymph node metastases vary depending on where the tumor is and how deeply it has invaded the stomach wall. They classified the lymph nodes into 33 distinct groups to help doctors communicate better about the cancer's spread. Who this helps: This benefits doctors and healthcare teams managing stomach cancer patients.

Plain English
This study looked at how surgery and treatments affect women with Krukenberg tumors (tumors that form in the ovaries from stomach cancer). Researchers followed 2,515 women diagnosed with gastric cancer, finding that 63 of them had Krukenberg tumors either at the same time as their stomach cancer or later. They discovered that women who developed these tumors later (metachronous) survived longer, with a median survival of 36 months, compared to only 17 months for those with tumors at the same time (synchronous). This research highlights the importance of carefully deciding who should undergo surgery, as it can lead to better outcomes for certain patients. Who this helps: This helps patients diagnosed with gastric cancer who may face Krukenberg tumors.

Plain English
This study looked at how surgical treatment affects survival for patients with retroperitoneal sarcomas, a type of rare cancer. They reviewed 107 patient records and found that after five years, 71% of patients were still alive, and 65% had no signs of the disease returning. The research showed that the aggressiveness of the tumor is the only factor affecting survival rates, highlighting the need for strong surgical intervention to improve patient outcomes. Who this helps: This helps patients with retroperitoneal sarcomas and their doctors in understanding the importance of surgery and tumor grading for better treatment planning.

Plain English
This study looked at a rare condition called McKittrick-Wheelock syndrome, caused by a large growth in the rectum, which led to serious symptoms like severe diarrhea and kidney failure in a 75-year-old woman. The patient experienced significant dehydration and electrolyte imbalances, but after doctors diagnosed the giant adenoma and performed surgery, she recovered well. Quick diagnosis and treatment are crucial for preventing serious complications in similar cases. Who this helps: This helps patients with rectal growths and their doctors in recognizing and treating this syndrome effectively.

Plain English
Researchers studied a new way to deliver the cancer drug doxorubicin directly to tumor cells using a specially designed nano-particle called HFt-MP-PAS. They found that this method was effective in targeting cancer cells and showed better results in mouse models compared to another drug delivery system currently being tested in clinical trials. This is important because it could lead to more effective treatments for cancer patients who don’t respond well to standard therapies. Who this helps: Patients with hard-to-treat cancers.

Plain English
This study looked at a technique to close the main pancreatic duct to prevent complications after a specific surgery called pancreaticoduodenectomy. Researchers analyzed data from 204 patients and found that 54% developed pancreatic fistulas post-surgery, with most being minor and manageable. One year later, 31% of patients had diabetes, and 88% had trouble digesting food. This technique is considered safe and could be especially beneficial for older patients or those with other health issues. Who this helps: This helps patients undergoing pancreatic surgery and their doctors.

Plain English
This study looked at the risk of leakage after surgery for rectal cancer in 475 patients. Researchers found that 9% experienced a leakage, with higher risks in patients whose tumors were closer to the anal opening and those who received blood transfusions during surgery. Using a temporary stoma reduced the need for additional surgeries significantly in patients with leakage, showing that it can lessen serious complications after surgery. Who this helps: This information helps patients recovering from rectal cancer surgery and their doctors.

Plain English
This study looked at how cancer affects certain genes related to muscle loss in patients with gastric cancer compared to healthy individuals. Researchers analyzed muscle samples from 38 cancer patients and 12 healthy controls, finding that levels of key atrophy-related genes like atrogin-1 and MuRF1 were similar in both groups, regardless of the cancer's stage or how much weight the patients lost. This is important because it shows that gastric cancer doesn’t seem to trigger muscle-related changes on a genetic level, which could help shape treatment and care strategies for these patients. Who this helps: This helps patients with gastric cancer and their doctors.

Plain English
This study examined whether using a tube through the nose to drain fluids helps patients avoid complications after stomach surgery for cancer. The researchers found that patients who had the tube placed experienced less stomach swelling and were able to pass gas faster—about 3.3 days compared to 4.3 days without the tube—showing a clear benefit in recovery time. However, there was no difference in serious complications or death rates between the two groups, indicating that using this tube after surgery isn't necessary. Who this helps: This helps patients undergoing stomach surgery for cancer and their doctors in deciding the best post-surgery care.

Plain English
This study focused on the characteristics and long-term outcomes of gastric stump cancer (GSC) in patients who developed cancer in the remaining stomach after having surgery for non-cancerous conditions. Researchers looked at 176 patients and found that after five years, about 53% were still alive. They also discovered that survival rates varied significantly depending on the cancer's stage: 68% for early-stage tumors, compared to only 17% for more advanced cases. Who this helps: This information is beneficial for doctors treating patients who have had stomach surgery, as it highlights the importance of monitoring for GSC and the potential success of aggressive surgical treatment.

Plain English
This study looked at a specific protein called CD10 in a group of 29 patients with gastrointestinal tumors known as GISTs. The researchers found that 24.1% of these tumors expressed CD10, but this didn't seem to affect the patients' prognosis, meaning it didn't help predict outcomes like survival or recurrence. However, they did notice that tumors with high mitotic counts (over 10 per 50 high power fields) in the stomach were associated with worse outcomes. Who this helps: This research is useful for doctors treating GIST patients, as it provides insights into the factors that influence patient outcomes.

Plain English
This study looked at trends in how gastric cancer patients have fared over 30 years at a major hospital in Italy, focusing on survival rates and surgical outcomes. Researchers found that, from 1980 to 2010, the rate of complications after surgery dropped to 19.4% and the death rate from surgery fell to 1.6%. Additionally, the five-year survival rate improved to 51%, with even better outcomes (64.5%) for patients who had complete tumor removal. Who this helps: This information benefits gastric cancer patients and their doctors by highlighting improvements in treatment and survival chances.

Plain English
This study looked at how treatment before surgery for rectal cancer affects the number of lymph nodes that can be removed during surgery and how this impacts patient survival. It found that patients who received neoadjuvant chemoradiotherapy had fewer lymph nodes removed (an average of 7) compared to those who went straight to surgery (12.5), but this lower count didn't mean worse outcomes; rather, it indicated that the treatment was effective. The survival rates for these patients were high, with 86.5% living at least five years after treatment. Who this helps: This helps patients undergoing treatment for rectal cancer and their doctors by clarifying the significance of the lymph node count after therapy.

Plain English
In the Cholegas Study, researchers looked at whether removing the gallbladder during gastric cancer surgery would cause more problems than just performing gastric surgery alone. Out of 130 patients, those who had their gallbladder removed experienced similar rates of complications, hospital stays, and costs as those who did not. This matters because it suggests that removing the gallbladder could be safely done along with cancer surgery, potentially preventing future issues without adding extra risks. Who this helps: This helps patients undergoing gastric surgery for cancer.

Plain English
This study looked at how to manage perforations (tears) in the digestive tract that can happen after a procedure called ERCP, based on data from 30 patients at a hospital in Rome. Researchers found that 50% of patients were treated successfully without surgery, while the other 50% had surgery, which took an average of about 8 days after the ERCP. The study highlights that while many patients can recover with conservative care, those in poor health or with infections need surgery quickly, as the risk of death can be significant—about 13% overall. Who this helps: This helps doctors and patients at risk of complications from ERCP procedures.

Plain English
This study looked at how a combination of treatments, including chemotherapy and radiation before surgery, affects people with rectal cancer. Out of 338 patients, those who received these treatments had a 5-year disease-specific survival rate of 80% and a disease-free survival rate of 73.1%. These results are important because they show that this approach leads to better survival outcomes and fewer local recurrences of cancer, particularly for advanced tumors. Who this helps: This helps patients with rectal cancer and their doctors in planning more effective treatment strategies.

Plain English
This study looked at whether a type of surgery called multivisceral resection is effective for patients with advanced stomach cancer that has spread to nearby organs. Among 206 patients with this condition, those who had the surgery faced a 3.6% chance of dying from the operation and a 33.9% chance of serious complications. Despite the risks, the five-year survival rate for these patients was 27.2%, indicating that this surgery can lead to acceptable outcomes when it's possible to remove all the cancer. Who this helps: This benefits patients with locally advanced stomach cancer.

Plain English
This study looked at the location of the arteries associated with hemorrhoids in 50 patients to find the best way to reduce blood flow to them. Researchers used imaging techniques to observe that most hemorrhoidal arteries are found just under the rectal lining within the last 2 centimeters above the anal opening. This information is important because understanding where these arteries are helps doctors perform more effective treatments for hemorrhoids. Who this helps: This helps patients with hemorrhoids seeking more effective treatment options.

Plain English
This study looked at a rare and severe case of T-cell lymphoma in a 55-year-old man, who had widespread abdominal issues and ended up needing surgery. Unfortunately, despite medical investigations, doctors could not determine the exact diagnosis before the surgery, leading to a rapid decline in his health and eventual death. The findings emphasize the importance of getting an accurate diagnosis before surgery in such severe cases, as surgery might not be the best option. Who this helps: This helps doctors in making better treatment decisions for patients with advanced lymphoma.

Plain English
This study looked at the best surgical methods for treating stomach cancer, specifically focusing on how many lymph nodes should be removed during surgery. Researchers found that removing more lymph nodes might not always be helpful and that in some cases, less extensive surgery leads to better recovery – particularly if the cancer has not spread extensively. Notably, up to 87.5% of patients can still experience cancer returning after surgery, highlighting the need for careful surgical decisions. Who this helps: This information benefits patients with stomach cancer by guiding treatment choices and improving recovery outcomes.

Plain English
This study examined patients with gastrointestinal stromal tumors (GISTs), which are tumors found in the digestive tract, by reviewing records from 50 patients treated in Rome over 17 years. Researchers found that the chances of surviving five years after treatment were around 66% overall, but factors like larger tumor size, a high rate of cell division, and tumor rupture lowered survival rates. Understanding these factors is important for improving treatment strategies and outcomes for patients with GISTs. Who this helps: This research benefits patients diagnosed with GISTs and their doctors by providing critical information for treatment planning.

Plain English
This study looked at a procedure called EUS-guided fine-needle tissue acquisition (EUS-FNTA) to sample tissue from potentially nonfunctioning pancreatic neuroendocrine tumors (NF-PETs) to measure Ki-67, a marker that helps predict how aggressive the tumor might be. Researchers successfully collected tissue samples from 93% of patients, with 93% of those samples allowing for Ki-67 analysis; importantly, the results were consistent between pre-surgery and post-surgery tests for most patients. This is significant because accurately determining Ki-67 can guide treatment choices for patients with these tumors. Who this helps: Patients with suspected nonfunctioning pancreatic neuroendocrine tumors.

Plain English
This study looked at the risks related to using heat during a specific cancer treatment called hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC). The researchers reviewed nine articles that reported complications like bowel perforation after HIPEC, noting that increased temperatures can harm healthy tissue alongside killing cancer cells. Understanding these risks is important because it helps doctors make safer treatment decisions for patients with advanced gastrointestinal cancers. Who this helps: This helps patients undergoing HIPEC and their doctors.

Plain English
This study looked at how to achieve successful surgery for gastric cancer in patients over 70 years old. They analyzed data from 1,465 patients and found that both older and younger patients had similar rates of complications after surgery (about 25% for the elderly vs. 21% for the younger group), but older patients had a five-year survival rate of 38.9%, compared to 58.9% for the younger patients. The findings suggest that age alone shouldn't stop older patients from getting this potentially life-saving surgery, as the risks and outcomes are similar to those of younger patients. Who this helps: This helps older patients with gastric cancer who need surgery.

Plain English
This study looked at whether nutrition support, which includes ways of providing food directly into the body, influences tumor growth and cancer progression in humans. The researchers reviewed various studies and found mixed and unclear results about how nutrition support affects tumors—specifically, they could not determine if it helps the tumors grow faster or affects how cancer cells die. Understanding this is important because it can guide how nutrition is used in cancer treatment to ensure it doesn’t harm patients. Who this helps: This helps patients undergoing cancer treatment and the doctors caring for them.

Plain English
This study looked at a new treatment called transanal haemorrhoidal dearterialization (THD) for severe fourth-degree hemorrhoids, which usually require painful surgery. Researchers treated 35 patients with THD and found that 94% reported relief or improvement in their symptoms after about 10 months. While some experienced minor issues like bleeding or pain, most side effects were temporary and only a few needed additional surgery. Who this helps: Patients suffering from severe hemorrhoids.

Plain English
This study focuses on gastrointestinal stromal tumors (GIST), which are rare tumors in the digestive system, making up about 1% of all gastrointestinal tumors. GISTs most often occur in the stomach (40-60%) and small intestine (30-40%), and can behave in ways that range from harmless to very dangerous. The treatment typically involves surgery for local tumors and a medication called Imatinib for those that have spread, though some patients develop resistance to Imatinib, prompting research into new treatment options. Who this helps: This research helps patients with GIST as well as doctors seeking to improve diagnosis and treatment strategies.

Plain English
This study looked at how a treatment for severe hemorrhoids, called transanal haemorrhoidal dearterialization (THD), affects bowel control and the function of the rectum. Researchers found that after the procedure, none of the 20 patients experienced serious issues with bowel control or incontinence, and the physical functioning of the rectum remained unchanged over six months. This is important because it shows that THD can effectively treat hemorrhoids without negatively impacting the patients' ability to control their bowel movements. Who this helps: This helps patients suffering from severe hemorrhoids who are looking for effective treatment options.